Jaclyn Cuccinello
Women's Health · Port Jefferson Station, NYNPI 1043476237
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 170 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,189, 2.7 times the $440 reported in 2021. Among women's health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $23.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$485
- Novo Nordisk$477
- Xeris Pharmaceuticals, Inc.$458
- AbbVie$360
- Lilly USA, LLC$347
- Mayne Pharma Commercial LLC$314
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,916100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,916 in reported general payments places this provider in the 95th percentile of 376 women's health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 154 | $270,527 |
| MounjaroTirzepatide | 76 | $155,252 |
| JardianceEmpagliflozin | 105 | $141,994 |
| TrulicityDulaglutide | 54 | $102,274 |
| FarxigaDapagliflozin Propanediol | 38 | $37,559 |
| RybelsusSemaglutide | 25 | $33,960 |
| TradjentaLinagliptin | 19 | $20,065 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $19,292 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $14,303 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $7,422 |
| SynthroidLevothyroxine Sodium | 34 | $3,343 |
| Metformin Hcl ErMetformin Hcl | 193 | $2,530 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,410 |
| Levothyroxine Sodium | 126 | $1,965 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 26 | $1,703 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $477 | $304,487179 claims |
| Lilly USA, LLCMounjaro, Trulicity | $347 | $257,526130 claims |
| Boehringer IngelheimJardiance, Tradjenta | $485 | $162,059124 claims |
| AstraZenecaFarxiga | $87 | $37,55938 claims |
| AbbVieSynthroid | $360 | $3,34334 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $238 | $1,965126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 376 women's health providers in New York.
Other women's health in Port Jefferson Station
- Sophia FrontusBrooklyn$52K
- Austin JacobusNew York$51K
- Jenna HortonAlbany$37K
- Stacie WierWilliamsville$12K
- Jenna GoldsmithWilliamsville$9K
- Mollie FinkelAlbany$7K
- Marjorie Seale-SimpsonMiddletown$6K
- Stacy GarrityNew York$5K
- Sarah WeldNew York$5K
- Kathleen CsillagNew York$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.